Orthopedic Conditions & Assessment

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which of the following are considered red flags when assessing orthopedic conditions?

Muscle weakness

Fatigue

Fractures (correct)

Joint stiffness

What are the '5Ps' associated with compartment syndrome?

Puffiness, pulsations, paresthesia, pain, paralysis

Pain, pallor, paresthesia, pulselessness, paralysis (correct)

Pain, pressure, peripheral pulse, position, paralysis

Pain, pallor, premium, paralysis, pressure

What indicates a fracture during the orthopedic assessment?

Swelling around the joint

Pain with squeezing of the bone (correct)

Increased range of motion

Decrease in muscle mass

Which test is NOT typically used to screen for fractures?

MRI imaging Signup and view all the answers

What can be a sign of dislocation in an orthopedic assessment?

Inability to move the damaged area Signup and view all the answers

Which hepatitis virus is associated with a primarily parenteral route of transmission?

Hepatitis B Signup and view all the answers

What is the average incubation period for Hepatitis C?

4-26 weeks Signup and view all the answers

Which hepatitis virus is most likely to lead to chronic liver disease?

Hepatitis C Signup and view all the answers

Which diagnostic method is used to confirm Hepatitis B infection?

Hep B surface or core antigens Signup and view all the answers

What characterizes the symptomatic icteric phase in hepatitis infections?

Jaundice appearance Signup and view all the answers

What is the primary mode of transmission for Hepatitis B?

Blood or sexual contact Signup and view all the answers

Which condition is characterized by a high risk of cirrhosis and hepatocellular carcinoma with long-term infection?

Chronic Hepatitis C Signup and view all the answers

What is a common feature of Non-Alcoholic Steatohepatitis (NASH)?

It is asymptomatic until severe hepatic failure occurs. Signup and view all the answers

Which statement about Hepatitis A is true?

It is primarily self-limited and rarely causes fulminant hepatic failure. Signup and view all the answers

What percentage of individuals with chronic Hepatitis C eventually develop cirrhosis?

20-30% Signup and view all the answers

What are the two main variants of esophageal carcinomas?

Adenocarcinoma and Squamous cell carcinoma Signup and view all the answers

What major risk factor is associated with squamous cell carcinoma of the esophagus?

Heavy alcohol and tobacco use Signup and view all the answers

Which mutation is commonly present at early stages of esophageal adenocarcinoma?

Mutation or overexpression of p53 Signup and view all the answers

In which part of the esophagus does esophageal adenocarcinoma typically occur?

Distal third Signup and view all the answers

Which of the following describes the initial presentation of esophageal adenocarcinoma?

Flat or raised patches in intact mucosa Signup and view all the answers

What is the primary demographic trend associated with gastric adenomas?

Incidence increases with age Signup and view all the answers

What is the relationship between the size of gastric adenomas and the risk of progression to adenocarcinoma?

Lesions > 2 cm have a significantly higher risk Signup and view all the answers

In which part of the stomach are gastric adenomas most commonly located?

Antrum Signup and view all the answers

Which type of gastric cancer comprises the majority of cases?

Adenocarcinoma Signup and view all the answers

Which geographical regions have the highest incidence of gastric adenocarcinoma?

Japan, Chile, and Eastern Europe Signup and view all the answers

What is the primary mechanism of action for H2 blockers in reducing stomach acid?

Competitive block of H2-R on parietal cells Signup and view all the answers

Which generic drug names typically indicate the use of H2 blockers?

Ranitidine, Famotidine Signup and view all the answers

In what condition would H2 blockers be less effective compared to PPIs?

Zollinger-Ellison syndrome Signup and view all the answers

What neurotransmitter primarily activates M3 receptors on parietal cells?

Acetylcholine Signup and view all the answers

Which of the following is NOT a common therapeutic use for H2 blockers?

Management of Zollinger-Ellison syndrome Signup and view all the answers

What is the primary mechanism of action of proton pump inhibitors (PPIs)?

Inhibition of H+, K+-ATPase Signup and view all the answers

What is the most common therapeutic use of PGE1 analogues?

Prevention of NSAID-induced ulcer Signup and view all the answers

Which of the following specific agents is classified as a proton pump inhibitor?

Esomeprazole Signup and view all the answers

What physiological effects do prostaglandins (PGs) have in the gastrointestinal tract?

Increased bicarbonate and mucous secretion Signup and view all the answers

Why are PGE1 analogues contraindicated in pregnant women?

They can induce uterine contractions Signup and view all the answers

Study Notes

Learning Objectives

Identify red flags and yellow flags in orthopedic assessments.
Understand pain sensation and its impact on specific tissues.
Describe the stages of injury and healing, and their respective treatment goals.
Compare normal and pathological end feels.
Define muscle spasm and guarding.

Red Flags

Include fractures, dislocations, infections, and compartment syndrome.
Fracture indicators: significant trauma history, age over 55, dark bruising, pain in a four-step test, inability to move the area.
Dislocations require a neurovascular screening and may need emergency intervention.
Compartment syndrome symptoms: pain, pallor, paresthesia, pulselessness, paralysis (the 5Ps).

Pain Sensitivity to Tissue

Most sensitive: Skin, Periosteum, and Fibrous Capsule.
Least sensitive: Fibrocartilage and Articular Cartilage.
Muscle injuries demonstrate dull ache and sharp pain, particularly upon movement or contraction.

Pain Assessment by Condition

Muscle Injury (Strain or Tendinopathy): Decreased Active Range of Motion (AROM), normal Passive Range of Motion (PROM), tenderness during resisted contraction.
Fascial Strain: Reduced AROM and PROM, potential subcutaneous adhesion.
Ligament Injury (Sprain): Painful end ROM, tenderness with palpation, may show instability.
Capsulitis: Pain with capsule palpation, limited motion in one direction, indicates muscular or tendon damage.
Joint Injury (Arthropathy): Mild loss of ROM, possible crepitus during motion.
Bone Injury (Fracture): Limited AROM and PROM with sharp pain, requires fracture assessment.
Nerve Injury: Reduced nerve functionality shows numbness and muscle weakness.

Stages of Healing

Acute Phase (1-5 days): Focus on pain reduction; employ massage, aquatic therapy, and pain-free exercises.
Functional Stage (2 weeks - 6 months): Goals include maintaining activity level and preventing recurrence; incorporate fast walking and sport-specific exercises.
Remodeling Phase (3 weeks - 12+ months): Focus on maintaining ability and reducing scar tissue; introduce strengthening exercises and ensure proper warm-up/stretching.

Treatment Guidelines Summary

Acute Phase: 2-3 days; apply PRICE/METH protocols and manage psychosocial factors.
Post-Acute Phase: 2 days - 6 weeks; aims include pain reduction and tissue alignment.
Chronic Phase: 2 weeks - 12+ months; emphasizes loading properly to enhance scar tissue elasticity and treat psychosocial issues.

Yellow Flags

Indicate risks for developing chronic pain; assess psychosocial factors if recovery is stagnant after 4-6 weeks.
Physical factors: inactivity, deconditioning; Psychological factors: depression, anxiety; Social context: work-related issues or poor support structures.

End Feel Types

Normal End Feel: RM Tissue Stretch, Soft Tissue Approximation, Ligamentous, and Bone to Bone identifiable by hard and painless resistance.
Pathological End Feel: Painful or restricted end feels like Muscle Spasm, Capsular, Springy Block, and Empty, indicating potential instability or injury.

Muscle Spasm and Guarding

Protective mechanisms causing involuntary contraction post-injury to reduce motion and pain.
Increased muscle tone may indicate upper motor neuron lesions.

Hepatitis Overview

Types of Hepatitis: A, B, C, D, and E, each with distinct genomic structures and transmission routes.
Transmission:
- Hepatitis A and E: Fecal-oral route.
- Hepatitis B, C, and D: Parenteral or sexual transmission.
Incubation Period: Ranges from 2-26 weeks, depending on the type.
Chronic Liver Disease:
- Hepatitis A: Never leads to chronic disease.
- Hepatitis B: 5-10% chronicity.
- Hepatitis C: Over 80% chronicity.
- Hepatitis D: Can worsen chronic hepatitis B.
- Hepatitis E: Rarely causes chronic liver disease.

Syndromes of Hepatitis Infection

Acute Symptomatic: Characterized by incubation, preicteric, icteric (jaundice), and convalescence phases.
Chronic Hepatitis: May present as a carrier state.
Fulminant Hepatic Failure: Rare but severe condition.

Hepatitis A

Common in areas with poor hygiene, with 30-50,000 new cases yearly in the US.
Almost always self-limited, with rare fulminant hepatic failure.
Clinical features include fatigue, nausea, and jaundice.

Hepatitis B

Most prevalent globally, often acquired at birth.
Can progress to cirrhosis or hepatocellular carcinoma.
Acute infections may show nonspecific symptoms, jaundice, and upper right quadrant pain.

Hepatitis C

Affects 1.6% of the population with chronic infection, primarily through blood-to-blood contact.
Hallmarked by persistent infection and chronic hepatitis, often asymptomatic.
Modern treatments provide significant cures, especially for genotypes 1a and 1b.

Hepatitis D & E

Hepatitis D: Requires coinfection with hepatitis B; can lead to acute severe hepatitis or chronic infections.
Hepatitis E: Zoonotic and self-limited; high mortality in pregnant women (up to 20%).

Alcoholic Liver Disease

Forms: Hepatitis, hepatic steatosis (reversible), and steatofibrosis (potentially leading to cirrhosis).
Clinical Features: Non-specific symptoms, including malaise and tender hepatomegaly; alcoholic hepatitis appears after heavy drinking.
Prognosis: Better outcome if detoxified; survival rates drop significantly with continued alcohol consumption.

Non-Alcoholic Fatty Liver Disease (NAFLD)

Most common liver disease in the US; encompasses non-alcoholic steatohepatitis (NASH).
NASH may progress to cirrhosis and increase liver cancer risk.
Clinical features often asymptomatic until late-stage liver failure occurs.

Drug and Toxin-Induced Liver Disease

Most common cause of fulminant hepatitis; categorized into predictable and unpredictable hepatotoxins.
Acetaminophen is a leading cause of acute liver failure necessitating transplantation.

Cirrhosis and Portal Hypertension

Caused by obstructed bile flow, leading to increased pressure and collateral circulation, resulting in esophageal varices.
Varices are prone to rupture, causing severe bleeding and high mortality rates.

Intrahepatic Biliary Tract Disease

Includes conditions like primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC).
Both conditions lead to liver damage and cirrhosis, with different initial symptoms and risk profiles.

Clinical Implications

Awareness of liver pathology and related diseases is crucial for diagnosis and treatment.
Persistent symptoms and risk factors should prompt further investigation into liver health.

Esophageal Carcinomas

Two main types: adenocarcinoma and squamous cell carcinoma.
Common yet highly fatal; 15,560 diagnoses and 13,940 deaths in the U.S. in 2007.
Risk factors for squamous cell carcinoma include tobacco/alcohol use, poverty, caustic injury, achalasia, and very hot beverages.
Adenocarcinoma risks are linked to long-standing GERD, Barrett’s esophagus, and tobacco; diets rich in fruits and vegetables provide protection.

Esophageal Adenocarcinoma - Etiology & Pathogenesis

Mutations accumulate in epithelial clones of Barrett's metaplasia leading to dysplasia and invasive carcinoma.
Early mutation or overexpression of p53 is common.
Additional genetic changes include amplification of c-ERB-B2, cyclin D1, and cyclin E genes, as well as RB mutations.

Esophageal Adenocarcinoma - Pathology

Typically found in the distal esophagus, potentially invading the gastric cardia.
Initial appearance as flat or raised patches in intact mucosa.
Large masses (≥ 5 cm) can form, possibly ulcerating or deeply invading.
Often associated with adjacent Barrett esophagus, resembling intestinal cells.

Gastric Adenoma - Introduction

Comprises 10% of all gastric polyps; incidence increases with age, predominantly in men aged 50-60.
Higher malignant potential compared to colonic adenomas.
Associated with chronic gastritis, gastric atrophy, and intestinal metaplasia.

Gastric Adenoma - Pathology

Usually solitary lesions < 2 cm, commonly in the stomach antrum.
Progression risk to adenocarcinoma increases with lesion size; ≥ 2 cm lesions show carcinoma in up to 30%.
Majority consist of intestinal-type columnar epithelium.

Gastric Adenocarcinoma - Introduction

Represents 90% of gastric cancers; classified as diffuse or intestinal types based on morphology.
Highest incidence in Japan, Chile, Costa Rica, and Eastern Europe; 20-fold higher than in North America.
North America has seen an 85% reduction in incidence since 1930, linked to lower H. pylori rates and reduced consumption of carcinogenic compounds.

Gastric Adenocarcinoma - Pathophysiology

Develops in chronic inflammatory settings.
Common mutations include p53 and E-cadherin loss; E-cadherin issues arise from germline mutations or hypermethylation.
Intestinal type mutations often activate the Wnt signaling pathway.

Gastric Adenocarcinoma - Pathology

Advanced cancers invade beneath the submucosa; classified into intestinal (glandular structures) and diffuse (mucous cells).
Both pathways involve stepwise mutation accumulation; BRAF mutations are common.

Colonic Adenocarcinoma - Pathogenesis

APC/β-catenin pathway accounts for 80% of sporadic colon tumors, initiating with mutations in the APC gene.
Loss of APC function leads to β-catenin accumulation, promoting cell proliferation.
Additional mutations arise, including KRAS and p53 mutations associated with chromosomal instability.

Colonic Adenocarcinoma - Microsatellite Instability Pathway

Due to loss of mismatch repair genes, mutations accumulate in microsatellite repeats.
Mutations may occur in genes regulating cell growth, including TGF-β receptors and pro-apoptotic proteins.

Hepatic Carcinoma - Clinical Features

Symptoms include upper abdominal pain, fatigue, weight loss, and possible awareness of an abdominal mass.
Enlarged liver may be palpable in many cases; prognosis for large tumors is poor, with most patients succumbing within two years.
Early detection of lesions < 2 cm greatly improves survival rates.

Pancreatic Cancer - Ductal Adenocarcinoma

Ductal adenocarcinoma is the primary type of pancreatic cancer and the 4th leading cause of cancer-related deaths.

Acid Suppressors

Mechanism of Action: Target gastric acid production through various pathways including antagonism of receptors such as H2-R and M3-R on parietal cells.
Adverse Effects: Potential for side effects like gastrointestinal disturbances, headaches, and dizziness; contraindications may include allergy to components or recent intestinal surgery.
Naming Conventions: Recognizable suffixes include "tidine" for H2 blockers (e.g., Cimetidine, Ranitidine, Famotidine) and "prazole" for proton pump inhibitors (e.g., Omeprazole, Esomeprazole).

H2 Blockers

Mechanism: Competitive blockade of H2 receptors on parietal cells reduces acid secretion.
Therapeutic Uses: Effective for peptic ulcers, non-malignant gastric and duodenal ulcers, and Zollinger-Ellison syndrome.
Associated Infections: Often used with "triple therapy" for H. pylori eradication.
Comparison with Other Agents: Antacids may provide faster relief for acute scenarios than H2 blockers.

Proton Pump Inhibitors (PPIs)

Mechanism: Inhibition of H+, K+-ATPase on gastric parietal cells reducing acid secretion.
Therapeutic Uses: Similar to H2 blockers, indicated for ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome.
First-Line Treatment: Commonly preferred in peptic ulcer triple therapy due to stronger acid suppression.

Prostaglandins and Analogs

Mechanism of Action: Decrease proton pump activity and increase mucous and bicarbonate secretion, therefore providing gastric protection.
Specific Agents: Misoprostol as a PGE1 analogue, mainly prevents NSAID-induced ulcers or GI bleed.
Contraindications: Not recommended for use in pregnant women due to risk of uterine contractions.

Motility Agents

Categories: Agents that decrease motility include Diphenoxylate-atropine and Loperamide; agents that increase motility include laxatives, Metoclopramide, and Domperidone.

Decreased Motility Agents

Diphenoxylate-atropine: Opioid receptor agonist that inhibits acetylcholine (ACh) release in the enteric system, leading to reduced gut motility.
Loperamide: Similar mechanism to diphenoxylate but without atropine; does not cross the blood-brain barrier, hence a lower risk of abuse.

Increased Motility Agents: Laxatives

Types of Laxatives: Include bulking agents (e.g., bran, psyllium), osmotic laxatives (e.g., magnesium sulfate, lactulose), chemical stimulants (e.g., Senna), and stool softeners (e.g., mineral oil, sodium docusate).

Metoclopramide

Increased Motility Mechanism: Blocks peripheral dopamine receptors boosting stimulative effects of ACh for peristalsis and lower esophageal sphincter tone.
Antinausea Mechanism: Central blockade of D2 receptors in the medulla for antiemetic action.
Therapeutic Uses: Effective for GERD, diabetic gastric stasis, and prevention of chemotherapy-induced nausea/vomiting.

General Notes

Anticholinergics: Include scopolamine and promethazine, used for nausea.
Dopamine-Receptor Blockers: Metoclopramide and Domperidone act as both motility enhancers and antiemetics.
Common Anticholinergic Side Effects: Dry mouth, reduced gastrointestinal motility.

Summary Considerations

Combination Therapy: Understanding interactions between these medications and their mechanisms is crucial for effective treatment of gastrointestinal disorders.
Patient Awareness: Important for patients to recognize possible side effects and when to seek advice, especially using drugs with abuse potential (e.g., opioids in cyclic usage).

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Description

This quiz focuses on important orthopedic conditions and assessment techniques covered in week 14. Students will learn to identify red and yellow flags, discuss pain sensation, and understand stages of injury and healing. Additionally, the quiz will cover normal and pathological end feels, as well as concepts such as muscle spasm and guarding.

Orthopedic Conditions & Assessment - Week 14

Choose a study mode